Delta Asia International Corporation (TPEX:6762)
Taiwan · Delayed Price · Currency is TWD 196.00
+5.00 (2.62%)
Dec 5, 2025, 1:00 PM CST
Delta Asia International Market Cap
Delta Asia International has a market cap or net worth of 6.89 billion as of December 5, 2025. Its market cap has decreased by -20.26% in one year.
Market Cap
6.89B
Enterprise Value
8.13B
Revenue
711.19M
Ranking
n/a
PE Ratio
116.26
Stock Price
196.00
Market Cap Chart
Since December 18, 2019, Delta Asia International's market cap has increased from 2.96B to 6.89B, an increase of 132.90%. That is a compound annual growth rate of 15.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 6.89B | -17.19% |
| Dec 27, 2024 | 8.32B | 19.54% |
| Dec 29, 2023 | 6.96B | 16.96% |
| Dec 30, 2022 | 5.95B | 4.15% |
| Dec 30, 2021 | 5.72B | 14.84% |
| Dec 31, 2020 | 4.98B | 69.81% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 258.22B |
| PharmaEssentia | 191.58B |
| Lotus Pharmaceutical | 78.89B |
| Bora Pharmaceuticals Co., LTD. | 65.31B |
| Lin BioScience | 34.87B |
| Oneness Biotech | 32.96B |
| Lumosa Therapeutics | 32.77B |
| Center Laboratories | 27.88B |